Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Currently in Phase III clinical trials, retatrutide is a triple agonist, meaning it targets three key metabolic pathways at once, GLP 1, GIP, and glucagon
What's still unconfirmed - the medical-group entity, full state list, exact billing cadence, and dispensing pharmacy - are reasonable things to weigh against the price before deciding it's worth it for you specifically
The company is also a great source of pharmaceutical-grade sermorelin at a time when such peptides are a little hard to come by, with numerous shady companies offering research-grade alternatives that are legitimately hazardous to humans who might take them
Tell your doctor or pharmacist right away if any of these side effects persist or worsen
